Skip to main content
SpringerLink
Log in

Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors

  • Head and Neck Oncology
  • Published:
European Archives of Oto-Rhino-Laryngology and Head & Neck Aims and scope Submit manuscript

Abstract

Biopsies from carcinoma tissue and benign control mucosa from head and neck squamous cell carcinoma (HNSCC) patients were used to establish fragment (F)-spheroids in vitro. We have previously shown that autologous monocytes co-cultured with F-spheroids in vitro augment their secretion of monocyte chemotactic protein-1 (MCP-1). Presently, the aims of the present work were to study whether the metabolic activity, secreted products and/or specific receptor/ligand on the surface of the F-spheroids and monocytes are necessary for stimulation of the monocyte MCP-1 secretion upon F-spheroid co-culture. Actinomycin D (1 μg/ml for 24 h) pre-treatment of the F-spheroids abolished the monocyte MCP-1 co-culture response. Co-culture of monocytes and F-spheroids separated by a semi-permeable membrane showed a decreased, but still present, monocyte MCP-1 co-culture response. Conditioned medium from F-spheroids stimulated allogenous monocytes to secrete MCP-1. The addition of glucose or galactose, but not mannose, to co-cultures partially inhibited the monocyte MCP-1 co-culture response. The addition of anti-CD14 antibody diminished the MCP-1 co-culture response. In conclusion, the monocyte MCP-1 co-culture response is dependent on metabolically active spheroids, secreted stimuli, and is augmented by direct contact with F-spheroids, possibly via lectin-like receptors and the CD14 receptor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1 A
Fig. 2
Fig. 3
Fig. 4
Fig. 5 A

Similar content being viewed by others

References

  1. Young MR (2004) Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 53:375–382

    Article  PubMed  Google Scholar 

  2. Kerrebijn JD, Balm AJ, Freeman JL, Dosch HM, Drexhage HA (1999) Who is in control of the immune system in head and neck cancer? Crit Rev Oncol Hematol 31:31–53

    PubMed  Google Scholar 

  3. Whiteside TL, Vujanovic NL, Herberman RB (1998) Natural killer cells and tumor therapy. Curr Top Microbiol Immunol 230:221–244

    PubMed  Google Scholar 

  4. Andreesen R, Hennemann B, Krause SW (1998) Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives. J Leukoc Biol 64:419–426

    PubMed  Google Scholar 

  5. Ferlazzo G, Munz C (2004) NK cell compartments and their activation by dendritic cells. J Immunol 172:1333–1339

    PubMed  Google Scholar 

  6. Burke B, Tang N, Corke KP, Tazzyman D, Ameri K, Wells M, Lewis CE (2002) Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J Pathol 196:204–212

    Article  PubMed  Google Scholar 

  7. Alexandroff AB, Robins RA, Murray A, James K (1998) Tumor immunology: false hopes—new horizons? Immunol Today 19:247–250

    Article  PubMed  Google Scholar 

  8. Basse PH, Whiteside TL, Herberman RB (2002) Cancer immunotherapy with interleukin-2-activated natural killer cells. Mol Biotechnol 21:161–170

    Article  PubMed  Google Scholar 

  9. Partridge M, Brakenhoff R, Phillips E, Ali K, Francis R, Hooper R, Lavery K, Brown A, Langdon J (2003) Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure. Clin Cancer Res 9:5287–5294

    PubMed  Google Scholar 

  10. Kim SY, Chu KC, Lee HR, Lee KS, Carey TE (1997) Establishment and characterization of nine new head and neck cancer cell lines. Acta Otolaryngol 117:775–784

    PubMed  Google Scholar 

  11. Sacks P (1996) Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev 15:27–51

    Article  PubMed  Google Scholar 

  12. Fjellbirkeland L, Bjerkvig R, Laerum OD (1995) Tumour fragment spheroids from human non-small-cell lung cancer maintained in organ culture. Virchows Arch 426:169–178

    Article  PubMed  Google Scholar 

  13. Heimdal J, Aarstad HJ, Olofsson J (2000) Monocytes secrete interleukin-6 when co-cultured in vitro with benign or malignant autologous fragment spheroids from squamous cell carcinoma patients. Scand J Immunol 51:271–278

    Article  PubMed  Google Scholar 

  14. Heimdal JH, Olsnes C, Olofsson J, Aarstad HJ (2001) Monocyte and monocyte-derived macrophage secretion of MCP-1 in co-culture with autologous malignant and benign control fragment spheroids. Cancer Immunol Immunother 50:300–306

    Article  PubMed  Google Scholar 

  15. Ward PA, Remold HG, David JR (1970) The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. Cell Immunol 1:162–174

    Article  PubMed  Google Scholar 

  16. Graves DT, Valente AJ (1991) Monocyte chemotactic proteins from human tumor cells. Biochem Pharmacol 41:333–337

    Article  PubMed  Google Scholar 

  17. Maghazachi AA, Al-Aoukaty A, Schall TJ (1996) CC chemokines induce the generation of killer cells from CD56+ cells. Eur J Immunol 26:315–319

    PubMed  Google Scholar 

  18. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, Oppenheim JJ (1995) Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 95:1370–1376

    PubMed  Google Scholar 

  19. Dawson J, Miltz W, Mir AK, Wiessner C (2003) Targeting monocyte chemoattractant protein-1 signalling in disease. Expert Opin Ther Targets 7:35–48

    Article  PubMed  Google Scholar 

  20. Boisvert WA (2004) Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 14:161–165

    Article  PubMed  Google Scholar 

  21. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, Wong SY, Gordon S (2002) Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 196:407–412

    Article  PubMed  Google Scholar 

  22. Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, Yamanaka T, Hirashima M, Liu FT (2000) Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 165:2156–2164

    PubMed  Google Scholar 

  23. Cambi A, Figdor CG (2003) Dual function of C-type lectin-like receptors in the immune system. Curr Opin Cell Biol 15:539–546

    Article  PubMed  Google Scholar 

  24. Olsnes C, Heimdal JH, Kross K, Olofsson J, Aarstad HJ (2002) Mechanisms for monocyte activation in co-culture with autologous tumor spheroids. Cell Immunol 219:11–21

    Article  PubMed  Google Scholar 

  25. Gorelik E, Galili U, Raz A (2001) On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev 20:245–277

    Article  PubMed  Google Scholar 

  26. Danguy A, Camby I, Kiss R (2002) Galectins and cancer. Biochim Biophys Acta 1572:285–293

    PubMed  Google Scholar 

  27. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433

    PubMed  Google Scholar 

  28. Heimdal JH, Aarstad HJ, Olsnes C, Olofsson J (2001) Human autologous monocytes and monocyte-derived macrophages in co-culture with carcinoma F-spheroids secrete IL-6 by a non-CD14-dependent pathway. Scand J Immunol 53:162–170

    Article  PubMed  Google Scholar 

  29. Heimdal JH, Aarstad HJ, Aakvaag A, Olofsson J (1997) In vitro T-lymphocyte function in head and neck cancer patients. Eur Arch Otorhinolaryngol 254:318–322

    PubMed  Google Scholar 

  30. Boyum A (1983) Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand J Immunol 17:429–436

    PubMed  Google Scholar 

  31. Steinsvag SK, Strand M, Berg O, Miaguchi M, Olofsson J (1991) Human respiratory mucosa in a nonadhesive stationary organ culture system. Laryngoscope 101:1323–1331

    PubMed  Google Scholar 

  32. Miller MJ (1987) Sensitivity of RNA synthesis to actinomycin D inhibition is dependent on the frequency of transcription: a mathematical model. J Theor Biol 129:289–299

    PubMed  Google Scholar 

  33. Kacani L, Wurm M, Schennach H, Braun I, Andrle J, Sprinzl GM (2003) Immunosuppressive effects of soluble factors secreted by head and neck squamous cell carcinoma on dendritic cells and T lymphocytes. Oral Oncol 39:672–679

    Article  PubMed  Google Scholar 

  34. Dobrovolskaia MA, Vogel SN (2002) Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 4:903–914

    Article  PubMed  Google Scholar 

  35. Heidenreich S, Schmidt M, August C, Cullen P, Rademaekers A, Pauels HG (1997) Regulation of human monocyte apoptosis by the CD14 molecule. J Immunol 159:3178–3188

    PubMed  Google Scholar 

  36. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD (1998) Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392:505–509

    Article  PubMed  Google Scholar 

  37. Liote F, Boval-Boizard B, Weill D, Kuntz D, Wautier JL (1996) Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release. Clin Exp Immunol 106:13–19

    Article  PubMed  Google Scholar 

  38. Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, Matsushima K (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6:3282–3289

    PubMed  Google Scholar 

  39. Weber KS, Nelson PJ, Grone HJ, Weber C (1999) Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 19:2085–2093

    PubMed  Google Scholar 

  40. Nesbit M, Schaider H, Miller TH, Herlyn M (2001) Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol 166:6483–6490

    PubMed  Google Scholar 

  41. Seljelid R, Jozefowski S, Sveinbjornsson B (1999) Tumor stroma. Anticancer Res 19:4809–4822

    PubMed  Google Scholar 

  42. Azuma I, Seya T (2001) Development of immunoadjuvants for immunotherapy of cancer. Int Immunopharmacol 1:1249–1259

    Article  PubMed  Google Scholar 

  43. Fukushima M (1996) Adjuvant therapy of gastric cancer: The Japanese experience. Semin Oncol 23:369–378

    PubMed  Google Scholar 

  44. Okamoto M, Ohe G, Oshikawa T, Nishikawa H, Furuichi S, Yoshida H, Matsuno T, Saito M, Sato M (2000) Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432, a penicillin-killed streptococcal agent. Immunopharmacology 49:363–376

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dagny Ann Sandnes and Turid Tynning for excellent technical assistance, and the Medical Research Center, University of Bergen, for providing parts of the laboratory facility used in this study. The work has been supported by The Norwegian Cancer Society.

Author information

Authors and Affiliations

  1. Department of Otolaryngology and Head and Neck Surgery, Haukeland University Hospital, 5021, Bergen, Norway

    Carla Olsnes, John-Helge Heimdal, Kenneth W. Kross, Jan Olofsson & Hans Jørgen Aarstad

  2. Broegelmann Research Laboratory, University of Bergen, Bergen, Norway

    Carla Olsnes, John-Helge Heimdal, Kenneth W. Kross, Jan Olofsson & Hans Jørgen Aarstad

Authors
  1. Carla Olsnes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John-Helge Heimdal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenneth W. Kross
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jan Olofsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hans Jørgen Aarstad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans Jørgen Aarstad.

Additional information

Parts of this paper were presented at the Sixth International Conference on Head and Neck Cancer in Washington, D.C.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olsnes, C., Heimdal, JH., Kross, K.W. et al. Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors. Eur Arch Otorhinolaryngol 262, 953–960 (2005). https://doi.org/10.1007/s00405-004-0902-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-004-0902-1

Keywords

Search

Navigation